What AtaiBeckley Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 6 |
| Total trades | 11 | 29 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 894,390 |
| Disposed | 56,328,403 | 56,703,155 |
| Net activity | −56,328,403 | −55,808,765 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Angermayer Christian | Director | Sep 11 | Disposition to Issuer · D | −1,799,302 | — | — | 0 |
| Angermayer Christian | Director | Sep 11 | Disposition to Issuer · D | −53,398,214 | — | — | 0 |
| Angermayer Christian | Director | Sep 11 | Disposition to Issuer · D | −559,232 | — | — | 0 |
| Smiley Andrea Heslin | Director | Sep 11 | Disposition to Issuer · D | −4,666 | — | — | 0 |
| Kalali Amir H | Director | Sep 11 | Disposition to Issuer · D | −4,666 | — | — | 0 |
| Short Glenn Frank | Chief Scientific Officer | Sep 11 | Disposition to Issuer · D | −42,333 | — | — | 0 |
| Barrett Christopher Ryan Cave | See remarks | Sep 11 | Disposition to Issuer · D | −155,066 | — | — | 0 |
| Johnson Anne Nagengast | Chief Accounting Officer | Sep 11 | Disposition to Issuer · D | −140,045 | — | — | 0 |
| Craig Kevin James | Chief Medical Officer | Sep 11 | Disposition to Issuer · D | −8,437 | — | — | 0 |
| Rao Srinivas | See remarks | Sep 11 | Disposition to Issuer · D | −3,500 | — | — | 0 |
| Rao Srinivas | See remarks | Sep 11 | Disposition to Issuer · D | −212,942 | — | — | 0 |
| Hershberg Robert | Director | Jul 07 | Disclosed 10b5-1 sale · S | −100,000 | $4.96 | −$496K | 100,000 |
| Hershberg Robert | Director | Jul 07 | Exercise / conversion · M | +51,142 | $1.35 | +$69K | 100,000 |
| Hershberg Robert | Director | Jul 07 | Exercise / conversion · M | +48,858 | $1.35 | +$66K | 48,858 |
| Kochendoerfer Gerd | Chief Operating Officer | Jun 26 | Disclosed 10b5-1 sale · S | −50,000 | $5.00 | −$250K | 0 |
| Kochendoerfer Gerd | Chief Operating Officer | Jun 26 | Exercise / conversion · M | +50,000 | $1.60 | +$80K | 50,000 |
| Craig Kevin James | Chief Medical Officer | Jun 25 | Disclosed 10b5-1 sale · S | −42,579 | $4.51 | −$192K | 8,437 |
| Craig Kevin James | Chief Medical Officer | Jun 25 | Exercise / conversion · M | +9,528 | $1.18 | +$11.2K | 51,016 |
| Craig Kevin James | Chief Medical Officer | Jun 25 | Exercise / conversion · M | +33,051 | $1.50 | +$49.6K | 41,488 |
| Craig Kevin James | Chief Medical Officer | Apr 20 | Disclosed 10b5-1 sale · S | −42,579 | $5.00 | −$213K | 8,437 |
Loading...
